(Q48687967)

English

Quantification of the Mg2+-induced potency shift of amantadine and memantine voltage-dependent block in human recombinant GluN1/GluN2A NMDARs

scientific article published on October 16, 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/20955720

Quantification of the Mg2+-induced potency shift of amantadine and memantine voltage-dependent block in human recombinant GluN1/GluN2A NMDARs (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/20955720

Aaron Lawson McLean

2

object named as

A. Lawson McLean

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20955720

4 August 2024

5

object named as

D. J A. Wyllie

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20955720

4 August 2024

author name string

H. J. Otton

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20955720

4 August 2024

M. A. Pannozzo

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20955720

4 August 2024

C. H. Davies

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20955720

4 August 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20955720

4 August 2024

publication date

16 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/20955720

full work available at URL

https://api.elsevier.com/content/article/PII:S0028390810002789?httpAccept=text/xml

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

https://api.elsevier.com/content/article/PII:S0028390810002789?httpAccept=text/plain

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Neuropharmacology

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/20955720

60

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/20955720

2-3

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/20955720

388-396

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/20955720

Some quantitative uses of drug antagonists

2

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

The role of divalent cations in the N-methyl-D-aspartate responses of mouse central neurones in culture

3

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition

4

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Trapping channel block of NMDA-activated responses by amantadine and memantine

5

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Amantadine inhibits NMDA receptors by accelerating channel closure during channel block.

6

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells

7

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Open-channel blockers at the human alpha4beta2 neuronal nicotinic acetylcholine receptor

8

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism

9

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Pharmacological implications of two distinct mechanisms of interaction of memantine with N-methyl-D-aspartate-gated channels

10

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes

11

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Pharmacological insights obtained from structure-function studies of ionotropic glutamate receptors

12

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies.

13

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block.

14

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Glutamate receptor gating.

15

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors.

16

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Structural determinants of the blocker binding site in glutamate and NMDA receptor channels

17

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices

18

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies

19

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Subunit arrangement and function in NMDA receptors

20

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors

21

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

The in vivo relevance of the varied channel-blocking properties of uncompetitive NMDA antagonists: tests on spinal neurones

23

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Channel blockers acting at N-methyl-D-aspartate receptors: differential effects of mutations in the vestibule and ion channel pore.

24

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex

25

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine

26

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Multiple structural elements determine subunit specificity of Mg2+ block in NMDA receptor channels

27

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Molecular diversity of the NMDA receptor channel

28

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Cloning, functional coexpression, and pharmacological characterisation of human cDNAs encoding NMDA receptor NR1 and NR2A subunits

29

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity

30

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Inhibition of human alpha 7 nicotinic acetylcholine receptors by open channel blockers of N-methyl-D-aspartate receptors.

31

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones

32

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Developmental and regional expression in the rat brain and functional properties of four NMDA receptors

33

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Heteromeric NMDA receptors: molecular and functional distinction of subtypes

34

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Therapeutically relevant plasma concentrations of memantine produce significant L-N-methyl-D-aspartate receptor occupation and do not impair learning in rats.

35

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Magnesium gates glutamate-activated channels in mouse central neurones

36

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in vitro and in vivo characterization

38

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data

39

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Memantine as an example of a fast, voltage-dependent, open channel N-methyl-D-aspartate receptor blocker

40

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan).

41

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo

42

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells

43

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

NR2 subunit-dependence of NMDA receptor channel block by external Mg2+.

44

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner

45

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

In vivo evidence for functional NMDA receptor blockade by memantine in rat hippocampal neurons.

46

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Interaction of memantine and amantadine with agonist-unbound NMDA-receptor channels in acutely isolated rat hippocampal neurons

47

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Glutamate receptor ion channels: structure, regulation, and function

48

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Potential role of N-methyl-D-aspartate receptors as executors of neurodegeneration resulting from diverse insults: focus on memantine

49

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Adjacent asparagines in the NR2-subunit of the NMDA receptor channel control the voltage-dependent block by extracellular Mg2+.

50

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Mg2+ and memantine block of rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes

51

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Taking the time to study competitive antagonism

52

1 reference

10.1016/J.NEUROPHARM.2010.10.008

https://api.crossref.org/works/10.1016/J.NEUROPHARM.2010.10.008

4 August 2024

Identifiers

10.1016/J.NEUROPHARM.2010.10.008

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/20955720

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/20955720

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48687967&oldid=2221035967"